Microbot Medical Enters Phase 2 Collaboration With Corewell Health To Advance Remote Telesurgery Using LIBERTY Endovascular Robotic System, Building On Successful Phase 1 Results
Portfolio Pulse from Benzinga Newsdesk
Microbot Medical has entered Phase 2 of its collaboration with Corewell Health to advance remote telesurgery using the LIBERTY Endovascular Robotic System, following successful Phase 1 results.

August 22, 2024 | 12:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Microbot Medical is advancing to Phase 2 in its collaboration with Corewell Health to develop remote telesurgery capabilities using its LIBERTY Endovascular Robotic System. This follows successful Phase 1 results, indicating progress in their innovative medical technology.
The advancement to Phase 2 in collaboration with Corewell Health suggests positive development and potential future success for Microbot Medical's LIBERTY system. The successful Phase 1 results provide a strong foundation, likely boosting investor confidence and potentially impacting the stock price positively in the short term.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90